Middle East & Africa Docetaxel Market Size & Outlook
Related Markets
MEA docetaxel market highlights
- The MEA docetaxel market generated a revenue of USD 51.6 million in 2024.
- The market is expected to grow at a CAGR of 5.2% from 2025 to 2030.
- In terms of segment, breast cancer was the largest revenue generating indication in 2024.
- Gastric Adenocarcinoma is the most lucrative indication segment registering the fastest growth during the forecast period.
- Country-wise, UAE is expected to register the highest CAGR from 2025 to 2030.
MEA data book summary
| Market revenue in 2024 | USD 51.6 million |
| Market revenue in 2030 | USD 70.1 million |
| Growth rate | 5.2% (CAGR from 2025 to 2030) |
| Largest segment | Breast cancer |
| Fastest growing segment | Gastric Adenocarcinoma |
| Historical data covered | 2018 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Breast Cancer, Non-Small Cell Lung Cancer (NSCLC), Hormone Refractory Prostate Cancer, Gastric Adenocarcinoma, Squamous Cell Carcinoma of the Head and Neck |
| Key market players worldwide | Phyton Biotech, Rochem, Alchem International, LGM Pharma, HRV Global LifeSciences, Teva Active Pharmaceutical Ingredients, Arch Pharmalabs, Aspen Pharmacare, Cipla Ltd DR |
Other key industry trends
- In terms of revenue, MEA region accounted for 4.1% of the global docetaxel market in 2024.
- Globally, Europe is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 474.2 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Docetaxel Market Scope
Docetaxel Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Teva Active Pharmaceutical Ingredients | View profile | 5001-10000 | http://www.tapi.com/ | |
| HRV Global LifeSciences | View profile | 101-250 | Hyderabad, Andhra Pradesh, India, Asia | https://hrvglobal.com |
| Alchem International | View profile | 11-50 | Delhi, Delhi, India, Asia | https://www.alchemlife.com |
| Rochem | View profile | 11-50 | Hauppauge, New York, United States, North America | https://rochemintl.com/ |
| Phyton Biotech | View profile | 51-100 | Delta, British Columbia, Canada, North America | http://www.phytonbiotech.com |
| Arch Pharmalabs | View profile | 5001-10000 | Mumbai, Maharashtra, India, Asia | http://www.archpharmalabs.com |
| Aspen Pharmacare | View profile | 10001+ | Durban, NA - South Africa, South Africa, Africa | https://www.aspenpharma.com |
| LGM Pharma | View profile | 101-250 | Nashville, Tennessee, United States, North America | https://lgmpharma.com/ |
| Cipla Ltd DR | View profile | 38955 | Ganpatrao Kadam Marg, Cipla House, Peninsula Business Park, Lower Parel, Mumbai, MH, India, 400 013 | https://www.cipla.com |
Middle East & Africa docetaxel market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to docetaxel market will help companies and investors design strategic landscapes.
Breast cancer was the largest segment with a revenue share of 34.88% in 2024. Horizon Databook has segmented the Middle East & Africa docetaxel market based on breast cancer, non-small cell lung cancer (nsclc), hormone refractory prostate cancer, gastric adenocarcinoma, squamous cell carcinoma of the head and neck covering the revenue growth of each sub-segment from 2018 to 2030.
The Middle East and Africa region is experiencing growing demand for docetaxel, particularly in Saudi Arabia and the UAE. Government-led cancer care initiatives, rising non-communicable disease prevalence, and infrastructure investments are key drivers. Access to chemotherapy is improving across public and private sectors.
Reasons to subscribe to Middle East & Africa docetaxel market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Middle East & Africa docetaxel market databook
-
Our clientele includes a mix of docetaxel market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa docetaxel market , including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa docetaxel market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
MEA docetaxel market size, by country, 2018-2030 (US$M)
Middle East & Africa Docetaxel Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Related statistics
No records
No related statistics found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
